John S. Shields
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
John S. Shields has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Ayobami S. Ogunsola
Department of Orthopaedic Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, United States
2 shared publications - Marcel G. Brown
Department of Orthopaedic Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, United States
2 shared publications - Matthew S. Gwilt
Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
2 shared publications - Xue Ma
Department of Orthopedic Surgery, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
2 shared publications - Ariel Mueller
Department of Anesthesiology, Massachusetts General Hospital, Mass General Brigham, Boston, MA
1 shared publication Ashley L. Talbott
Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
1 shared publication
Latest Publications
- Open Access
- 12 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 8 (1) , 100729
Acellular placental extract outcomes in post-traumatic osteoarthritis model
- 12 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 8 (1) , 100729
Open AccessAcellular placental extract outcomes in post-traumatic osteoarthritis model
- 6 May 2025
- Published by Springer Nature
- p. 323-326
Calcar Replacing Stems in Revision Total Hip Arthroplasty
- 6 May 2025
- Published by Springer Nature
- p. 323-326
Calcar Replacing Stems in Revision Total Hip Arthroplasty
- Open Access
- 19 April 2025
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 145 (1) , 1-11
The effect of Charlson Comorbidity Index, race, and surgical complications on postoperative knee outcomes after total knee arthroplasty
Introduction: Total Knee Arthroplasty (TKA) is the primary definitive treatment for knee osteoarthritis (OA) and has been essential in helping patients reduce knee pain and regain mobility. There is a need to assess whether various factors such as surgical complications from primary TKA, pre and postoperative range of motion (ROM), Charlson Comorbidity Index (CCI), comorbidities other than CCI, and demographics representative of an outpatient TKA population affect patient-reported outcome measures (PROMs). Materials and methods: Retrospective chart review was performed on 444 patients who underwent TKA at an outpatient surgical facility. Demographics, qualitative, and quantitative measurements were collected at baseline, 4–6 months, and 1-year postoperatively. Patients were stratified by CCI into low (< 2), moderate (2–4), and high (> 4) risk categories. A generalized linear model was used to assess the relationship between time, complications, risk categories, and Knee injury and Osteoarthritis Outcome Score Joint Replacement (KOOS, JR). Results: Majority of patients were women (58.9%), non-Hispanic white (81.9%), categorized as moderate risk CCI (78.8%), with 22.5% experiencing complications post-TKA. KOOS, JR scores improved over time, with an increase of 18.1 points at 4–6 months and 26.1 points at 1-year post-TKA ( p < 0.0001). Surgical complications were linked to a decrease of 3.5 points in KOOS, JR scores, whereas patients with high pre-TKA KOOS, JR scores had an increase of 6.4 points after surgery. Patients who identified as African American experienced an average of 4.7 points lower on KOOS, JR than non-Hispanic whites ( p = 0.0211). High-risk patients (CCI > 4) on average, had higher KOOS, JR scores 12 months after TKA. African Americans and those with surgical complications reported Lower KOOS, JR scores. Conclusions: TKA improved KOOS, JR scores through one year with the greatest improvement in PROM being in higher-risk patients, those without surgical complications. Patients with surgical complications and/or African American race had a lower average KOOS, JR score.
- 19 April 2025
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 145 (1) , 1-11
Open AccessThe effect of Charlson Comorbidity Index, race, and surgical complications on postoperative knee outcomes after total knee arthroplasty
Introduction: Total Knee Arthroplasty (TKA) is the primary definitive treatment for knee osteoarthritis (OA) and has been essential in helping patients reduce knee pain and regain mobility. There is a need to assess whether various factors such as surgical complications from primary TKA, pre and postoperative range of motion (ROM), Charlson Comorbidity Index (CCI), comorbidities other than CCI, and demographics representative of an outpatient TKA population affect patient-reported outcome measures (PROMs). Materials and methods: Retrospective chart review was performed on 444 patients who underwent TKA at an outpatient surgical facility. Demographics, qualitative, and quantitative measurements were collected at baseline, 4–6 months, and 1-year postoperatively. Patients were stratified by CCI into low (< 2), moderate (2–4), and high (> 4) risk categories. A generalized linear model was used to assess the relationship between time, complications, risk categories, and Knee injury and Osteoarthritis Outcome Score Joint Replacement (KOOS, JR). Results: Majority of patients were women (58.9%), non-Hispanic white (81.9%), categorized as moderate risk CCI (78.8%), with 22.5% experiencing complications post-TKA. KOOS, JR scores improved over time, with an increase of 18.1 points at 4–6 months and 26.1 points at 1-year post-TKA ( p < 0.0001). Surgical complications were linked to a decrease of 3.5 points in KOOS, JR scores, whereas patients with high pre-TKA KOOS, JR scores had an increase of 6.4 points after surgery. Patients who identified as African American experienced an average of 4.7 points lower on KOOS, JR than non-Hispanic whites ( p = 0.0211). High-risk patients (CCI > 4) on average, had higher KOOS, JR scores 12 months after TKA. African Americans and those with surgical complications reported Lower KOOS, JR scores. Conclusions: TKA improved KOOS, JR scores through one year with the greatest improvement in PROM being in higher-risk patients, those without surgical complications. Patients with surgical complications and/or African American race had a lower average KOOS, JR score.
- Open Access
Effect of surgical approach to hip arthroplasty on postoperative pain and mobilization and on efficacy of intrathecal oxytocin for pain
Objective Compare the effect of posterior surgical approach (PA) vs direct anterior approach (DAA) on speed of recovery from pain and dysfunction and on intrathecal oxytocin analgesia after total hip arthroplasty (THA). Study design Nested cohort within a randomized, controlled, double-blind trial Setting Hospital Subjects Individuals aged 31 to 80 years undergoing total hip arthroplasty (THA) Methods In this secondary analysis of a randomized controlled trial, the association between surgical approach and number of daily steps was assessed, and whether this was modified by receipt of intrathecal oxytocin. Data were collected from accelerometers and daily patient diaries in the first eight weeks postoperatively. Outcomes were analyzed using generalized linear regression models. Results Ninety patients underwent THA, of which 35 (38.9%) received a PA. Patients were predominantly female (57.8%) with a mean age of 60.6 (standard deviation [SD] 9.3) years. On postoperative day one patients who received a PA with placebo took more steps (mean difference [MD] 53.72, 95% CI: −1717.86, 1825.31) than patients who underwent a DAA. Trajectories were significantly modified by whether they received oxytocin, in which patients who underwent PA with oxytocin took more steps than patients who underwent DAA (pDiscussion Further studies are needed to understand mechanisms underlying oxytocin’s interaction with surgical approach and guide considerations for recovery after THA.
Open AccessEffect of surgical approach to hip arthroplasty on postoperative pain and mobilization and on efficacy of intrathecal oxytocin for pain
Objective Compare the effect of posterior surgical approach (PA) vs direct anterior approach (DAA) on speed of recovery from pain and dysfunction and on intrathecal oxytocin analgesia after total hip arthroplasty (THA). Study design Nested cohort within a randomized, controlled, double-blind trial Setting Hospital Subjects Individuals aged 31 to 80 years undergoing total hip arthroplasty (THA) Methods In this secondary analysis of a randomized controlled trial, the association between surgical approach and number of daily steps was assessed, and whether this was modified by receipt of intrathecal oxytocin. Data were collected from accelerometers and daily patient diaries in the first eight weeks postoperatively. Outcomes were analyzed using generalized linear regression models. Results Ninety patients underwent THA, of which 35 (38.9%) received a PA. Patients were predominantly female (57.8%) with a mean age of 60.6 (standard deviation [SD] 9.3) years. On postoperative day one patients who received a PA with placebo took more steps (mean difference [MD] 53.72, 95% CI: −1717.86, 1825.31) than patients who underwent a DAA. Trajectories were significantly modified by whether they received oxytocin, in which patients who underwent PA with oxytocin took more steps than patients who underwent DAA (pDiscussion Further studies are needed to understand mechanisms underlying oxytocin’s interaction with surgical approach and guide considerations for recovery after THA.
- 1 October 2023
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 13 (4)
Retained Gastric Contents After Adequate Fasting Associated with GLP-1 Receptor Agonist Use
Cases: Three patients presented for orthopaedic surgery on glucagon-like peptide receptor agonist (GLP-1 RA) medications with a minimum fasting time of 10 hours. Gastric ultrasound confirmed the presence of retained solids in the stomach; all 3 cases were postponed. Conclusion: There is growing concern for increased perioperative aspiration risk related to delayed gastric emptying associated with GLP-1 RA and a paucity of literature to guide perioperative management. This may cause case cancellation over safety concerns for elective procedures. The presented cases illustrate the association of GLP-1 RA drugs and delayed gastric emptying causing case postponement.
- 1 October 2023
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 13 (4)
Retained Gastric Contents After Adequate Fasting Associated with GLP-1 Receptor Agonist Use
Cases: Three patients presented for orthopaedic surgery on glucagon-like peptide receptor agonist (GLP-1 RA) medications with a minimum fasting time of 10 hours. Gastric ultrasound confirmed the presence of retained solids in the stomach; all 3 cases were postponed. Conclusion: There is growing concern for increased perioperative aspiration risk related to delayed gastric emptying associated with GLP-1 RA and a paucity of literature to guide perioperative management. This may cause case cancellation over safety concerns for elective procedures. The presented cases illustrate the association of GLP-1 RA drugs and delayed gastric emptying causing case postponement.
- 2 December 2022
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 38 (5) , 824-830
Comparison of Femoral Nerve Catheter, Adductor Canal Catheter, and Periarticular Liposomal Bupivacaine Infiltration for Postoperative Analgesia After Primary Total Knee Arthroplasty
- 2 December 2022
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 38 (5) , 824-830
Comparison of Femoral Nerve Catheter, Adductor Canal Catheter, and Periarticular Liposomal Bupivacaine Infiltration for Postoperative Analgesia After Primary Total Knee Arthroplasty
- 15 July 2022
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 105 (1) , 83-84
What's Important (Arts & Humanities): Recon
- 15 July 2022
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 105 (1) , 83-84
What's Important (Arts & Humanities): Recon
- 11 July 2022
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 104 (22) , 2038-2040
What’s Important: Landscapes of North Carolina
- 11 July 2022
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 104 (22) , 2038-2040
What’s Important: Landscapes of North Carolina
- Open Access
- 21 March 2022
- Published by Elsevier in Arthroplasty Today
- Vol. 15, 1-5
Closing Time: One Last Call for Patient Preference
- 21 March 2022
- Published by Elsevier in Arthroplasty Today
- Vol. 15, 1-5
Open AccessClosing Time: One Last Call for Patient Preference
- 28 September 2021
- Published by Springer Nature in Current Reviews in Musculoskeletal Medicine
- Vol. 14 (5) , 316-319
The Clinical Application of Augmented Reality in Orthopaedics: Where Do We Stand?
Purpose of Review The surgical community is constantly working to improve accuracy and reproducibility in patient care, with the goal to improve patient outcomes and efficiency. One area of growing interest with potential to meet these goals is in the use of augmented reality (AR) in surgery. There is still a paucity of published research on the clinical benefits of AR over traditional techniques, but this article aims to present an update on the current state of AR within orthopaedics over the past 5 years. Recent Findings AR systems are being developed and studied for use in all areas of orthopaedics. Most recently published research has focused on the areas of fracture care, adult reconstruction, orthopaedic oncology, spine, and resident education. These studies have shown some promising results, particularly in surgical accuracy, decreased surgical time, and less radiation exposure. However, the majority of recently published research is still in the pre-clinical setting, with very few studies using living patients. Summary AR supplementation in orthopaedic surgery has shown promising results in pre-clinical settings, with improvements in surgical accuracy and reproducibility, decreased operating times, and less radiation exposure. Most AR systems, however, are still not approved for clinical use. Further research is needed to validate the benefits of AR use in orthopaedic surgery before it is widely adopted into practice.
- 28 September 2021
- Published by Springer Nature in Current Reviews in Musculoskeletal Medicine
- Vol. 14 (5) , 316-319
The Clinical Application of Augmented Reality in Orthopaedics: Where Do We Stand?
Purpose of Review The surgical community is constantly working to improve accuracy and reproducibility in patient care, with the goal to improve patient outcomes and efficiency. One area of growing interest with potential to meet these goals is in the use of augmented reality (AR) in surgery. There is still a paucity of published research on the clinical benefits of AR over traditional techniques, but this article aims to present an update on the current state of AR within orthopaedics over the past 5 years. Recent Findings AR systems are being developed and studied for use in all areas of orthopaedics. Most recently published research has focused on the areas of fracture care, adult reconstruction, orthopaedic oncology, spine, and resident education. These studies have shown some promising results, particularly in surgical accuracy, decreased surgical time, and less radiation exposure. However, the majority of recently published research is still in the pre-clinical setting, with very few studies using living patients. Summary AR supplementation in orthopaedic surgery has shown promising results in pre-clinical settings, with improvements in surgical accuracy and reproducibility, decreased operating times, and less radiation exposure. Most AR systems, however, are still not approved for clinical use. Further research is needed to validate the benefits of AR use in orthopaedic surgery before it is widely adopted into practice.